519-55-1
519-55-1
Chemical Structure
Cyrtominetin
- CAS No.: 519-55-1
- Formula:C17H16O6
- Molecular Weight:316.31
IUPAC Name: (S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6,8-dimethylchroman-4-one
InChIKey: AESMRHCYHARBLU-ZDUSSCGKSA-N
SMILES: OC1=C2C(O[C@@H](CC2=O)C3=CC(O)=C(O)C=C3)=C(C)C(O)=C1C
Biological Activity: Cyrtominetin is a RANKL inhibitor with favorable ADMET properties. Cyrtominetin competitively blocks the binding of RANKL-RANK and increases the compactness of RANKL. Cyrtominetin can be used in studies related to osteoporosis[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Cyrtominetin | Cyrtominetin is a RANKL inhibitor with favorable ADMET properties. Cyrtominetin competitively blocks the binding of RANKL-RANK and increases the compactness of RANKL. Cyrtominetin can be used in studies related to osteoporosis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Zhang X, et al. Computational exploration of Eucommia ulmoides flavonoids as potential RANKL inhibitors via molecular docking and dynamics simulations. Scientific reports. 2025 May 17;15(1):17175. [Content Brief]
- [2]. Zhang X, et al. Computational study of flavonoids from Eucommia ulmoides against RANKL-induced osteoclastogenesis using Molecular Docking and molecular dynamics simulation[J]. 2025.
